Pages that link to "Q26740594"

The following pages link to Contemporary Treatment of Metastatic Renal Cell Carcinoma (Q26740594):

Displaying 19 items.

• Cabozantinib Versus Sunitinib As Initial Targeted Therapy for Patients With Metastatic Renal Cell Carcinoma of Poor or Intermediate Risk: The Alliance A031203 CABOSUN Trial. (Q36281483) (← links)
• Systematic expression analysis of the mitochondrial complex III subunits identifies UQCRC1 as biomarker in clear cell renal cell carcinoma (Q37699265) (← links)
• Pazopanib: a Review in Advanced Renal Cell Carcinoma (Q38701057) (← links)
• Lenvatinib for use in combination with everolimus for the treatment of patients with advanced renal cell carcinoma following one prior anti-angiogenic therapy (Q38754614) (← links)
• RIP1-dependent reactive oxygen species production executes artesunate-induced cell death in renal carcinoma Caki cells. (Q38807587) (← links)
• Eligibility for phase 3 clinical trials of systemic therapy in real-world patients with metastatic renal cell cancer managed in a rural region (Q40490003) (← links)
• Angiogenic, inflammatory and immunologic markers in predicting response to sunitinib in metastatic renal cell carcinoma. (Q41595498) (← links)
• Translating new data to the daily practice in second line treatment of renal cell carcinoma: The role of tumor growth rate (Q42365081) (← links)
• The triple angiokinase inhibitor nintedanib directly inhibits tumor cell growth and induces tumor shrinkage via blocking oncogenic receptor tyrosine kinases. (Q47771087) (← links)
• Pembrolizumab and its role in relapsed/refractory classical Hodgkin's lymphoma: evidence to date and clinical utility. (Q52721221) (← links)
• The Evolving Treatment Landscape of Advanced Renal Cell Carcinoma in Patients Progressing after VEGF Inhibition. (Q53153700) (← links)
• Correlation of c-MET Expression with PD-L1 Expression in Metastatic Clear Cell Renal Cell Carcinoma Treated by Sunitinib First-Line Therapy. (Q53263432) (← links)
• Clival metastasis of renal clear cell carcinoma: Case report and literature review (Q58761578) (← links)
• Real-world outcomes of nivolumab and cabozantinib in metastatic renal cell carcinoma: results from the International Metastatic Renal Cell Carcinoma Database Consortium (Q64090931) (← links)
• Limitations to the Therapeutic Potential of Tyrosine Kinase Inhibitors and Alternative Therapies for Kidney Cancer. (Q64929569) (← links)
• Important Group Differences on the Functional Assessment of Cancer Therapy-Kidney Symptom Index Disease-Related Symptoms in Patients with Metastatic Renal Cell Carcinoma (Q90018185) (← links)
• Therapeutic Sequencing in Metastatic Renal Cell Carcinoma (Q92372105) (← links)
• Peglated-H1/pHGFK1 nanoparticles enhance anti-tumor effects of sorafenib by inhibition of drug-induced autophagy and stemness in renal cell carcinoma (Q92705174) (← links)
• Rare patients in routine care: Treatment and outcome in advanced papillary renal cell carcinoma in the prospective German clinical RCC-Registry (Q93196796) (← links)